Cargando…
Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells
Acute myeloid leukemia (AML) is an hematologic neoplasia characterized by the accumulation of transformed immature myeloid cells in bone marrow. Although the response rate to induction therapy is high, survival rate 5-year after diagnosis is still low, highlighting the necessity of new novel agents....
Autores principales: | Cornet-Masana, Josep Maria, Moreno-Martínez, Daniel, Lara-Castillo, María Carmen, Nomdedeu, Meritxell, Etxabe, Amaia, Tesi, Niccolò, Pratcorona, Marta, Esteve, Jordi, Risueño, Ruth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029623/ https://www.ncbi.nlm.nih.gov/pubmed/26992240 http://dx.doi.org/10.18632/oncotarget.8096 |
Ejemplares similares
-
XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
por: Moreno-Martínez, Daniel, et al.
Publicado: (2014) -
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
por: Nomdedeu, Meritxell, et al.
Publicado: (2015) -
Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016) -
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
por: Banús-Mulet, Antònia, et al.
Publicado: (2018) -
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023)